PROVIDING EARLY ACCESS TO DRUGS IN DEVELOPMENT
myTomorrows provides physicians and patients that are excluded from clinical trials access to drugs in development. We focus on disease areas with unmet needs; oncology, neurology, psychiatry and rare diseases. myTomorrows identifies innovative drugs, informs physicians and patients and facilitates requests for access to these drugs in development.REGISTER AT MYTOMORROWS
Drug development takes about twelve years from discovery to marketing authorization. Drugs that show promising results during clinical development need to be tested in large patient populations before receiving marketing authorization. In many cases patients with high unmet medical needs that are excluded from clinical trials, can’t afford to wait the extra years it takes for a drug to receive such a marketing authorization.
Expanded Access Programs enable physicians and patients who have exhausted other medicinal treatment options to access development stage drugs or drugs that have marketing authorization elsewhere, but not yet in their home country.LEARN MORE...
Identify drug developments. Our physicians and bio-medical specialists identify the latest drug developments from across the globe.
Inform. Physicians and pharmacists can register online and request information about the drugs myTomorrows provides access to.
Facilitate requests. In most countries health authorities must grant permission for treatment with a non-registered drug. myTomorrows facilitates requests for permission for physicians and pharmacists.